
Read More
Eugia Pharma receives USFDA Approval for Dasatinib Tablets...
The company has a market cap of over Rs 70,000 crore and the stock is up by 23 per cent from its 52-...

The company has a market cap of over Rs 70,000 crore and the stock is up by 23 per cent from its 52-...

The stock gave multibagger returns of 190 per cent in 2 years and a whopping 500 per cent in 5 years...

The biosimilars division alongside niche product development represents Aurobindo Pharma's main focu...

The company's wholly-owned subsidiary, Nureca Technologies Pvt Ltd, specializes in manufacturing med...

The company has a market cap of over Rs 1 lakh crore and the stock is up by 13 per cent from its 52-...

The facility in question, Unit-V, is an active pharmaceutical ingredient (API) manufacturing site op...

With the USFDA's green light, the Indian pharmaceutical company is poised to expand its product port...

The share has delivered over 95 per cent returns in the past year, transforming into a multi-bagger ...

This pharma company stock went 8 per cent high, do you own it? ...

At 2.30 pm on Thursday, the markets were seen recovering from the day’s low as Asia- Pacific markets...